1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices

In this report, biopharmaceutical manufacturer decision-makers share their perspectives on:
- Expected outsourcing of commercial biosimilar manufacturing
- Comfort level with outsourcing to individual CMOs
- Market trends and biosimilar manufacturing method preferences

Methodologies:
ISR conducted 68 online quantitative surveys with respondents from biopharmaceutical companies who:
- Have significant influence over outsourced commercial manufacturing activities
- Have been involved in outsourcing commercial manufacturing activities within the past 18 months

How you can use this report:
Manufacturers
- Stay on top of industry trends by learning what biopharmaceutical companies currently manufacturing large molecules think the future holds for biosimilar manufacturing
- Learn what methods of biosimilar manufacturing peers are gravitating towards
- Understand where, geographically, biopharmaceutical companies are looking to manufacturer biosimilars
CMOs
- Start to understand the market potential for outsourced biosimilar manufacturing
- Learn what biopharmaceutical companies would value from a CMO and leverage these drivers in your sales and marketing efforts
- Get an early indication of market leaders by knowing which manufacturers and CMOs respondents would be most comfortable using for biosimilar production

Table Of Contents

Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices
Table of Contents

Copyright and Usage Guidelines ..3
Introduction .4
Methodology ...5
Summary Respondent Demographics ..6
Years of Industry Experience .6
Geography .6
Company Size .6
Study Data 7
Biosimilar familiarity ..8
Large molecule products offering ..9
Large vs. small molecule outsourcing ..10
Large molecule manufacturing: in-house vs. outsourcing ...11
Stance on selling biosimilars 12
Stance on manufacturing biosimilars ...13
Biosimilar manufacturing methods ..14
Outsourced biosimilars manufacturing activities .15
Primary biosimilar outsourcing drivers 16
Biosimilar manufacturing, by geography .17
Biosimilar outsourcing comfort, by company ..18
Most difficult aspect of biosimilar manufacturing, unprompted .19
Respondent's likelihood to use biosimilars ..20
Respondent Demographics 21
Company type ..22
Decision making responsibility .23
Primary area of decision making responsibility ...24
Outsourcing influence ..25
Commercial manufacturing responsibilities .26
Job title .27
Involvement in manufacturing process 28
Headquarters location ..29
Office location ..30
Commercial manufacturing activity involvement 31
Years of industry experience 32
About Industry Standard Research 33

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

  • $ 4550
  • Industry report
  • January 2017
  • by Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present ...

Global Biosimilars Market-Growth, Trends & Forecasts. (2017 - 2022)

Global Biosimilars Market-Growth, Trends & Forecasts. (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Biosimilars Market was valued at USD 5237.0 currently and is projected to reach USD 28200.0 million by 2020, at a CAGR of 40.3% during the forecast period from 2015 to 2021. The global biosimilars ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.